Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- priority_score
- Composite prioritisation = 0.30*biology + 0.30*reagent-gap + 0.20*druggability + 0.10*disease + 0.10*novelty. Sub-scores are assigned during LLM-assisted curation — a heuristic ranking, NOT an experimental measurement.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- 1 if in the EV-Map circulating-EV proteome (Rai 2025); 3,422 targets.
- has_known_aptamer
- 1 if aptamer evidence found in PubMed/Aptagen (1,472 targets).
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for this protein AND (aptamer OR SELEX).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
239 rows where has_cryoEM = 1, in_cev_map = 1 and tier = "Tier 1.5" sorted by priority_score descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 239 ✖
in_cev_map 1
- 1 · 239 ✖
has_cryoEM 1
- 1 · 239 ✖
has_activation_state_pdb_pair 1
- 0 239
| id | gene_symbol | protein_name | tier | priority_score ▲ | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | drug_count_approved | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P25445 | FAS | Tumor necrosis factor receptor superfamily member 6 | Tier 1.5 | 0.914 | 7 | 77.88 | 1 | 0 | 1 | 17 | 40784034, 39897575, 37458448, 36908619, 35402075, 32270033, 31436946, 30594071, 30417194, 30339905, 26318819, 23980164, 23511245, 18997060, 18956014, 16729304, 16581027 | 1 | autoimmune lymphoproliferative syndrome type 1 | 0.7377210386590284 | |||
| Q02094 | RHAG | Ammonium transporter Rh type A | Tier 1.5 | 0.841 | 8 | 95.62 | 1 | 0 | 0 | 0 | 1 | Rh deficiency syndrome | 0.764209214915708 | ||||
| Q14392 | LRRC32 | Transforming growth factor beta activator LRRC32 | Tier 1.5 | 0.838 | 6 | 86.06 | 1 | 0 | 0 | 0 | 1 | cleft palate, proliferative retinopathy, and developmental delay | 0.5770707112957068 | ||||
| P12532 | CKMT1A | Creatine kinase U-type, mitochondrial | Tier 1.5 | 0.83 | 9 | 89.31 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5385822922582763 | ||||
| P54709 | ATP1B3 | Sodium/potassium-transporting ATPase subunit beta-3 | Tier 1.5 | 0.81 | 7 | 89.69 | 1 | 0 | 0 | 0 | 1 | congestive heart failure | 0.5999952111132625 | ||||
| P02748 | C9 | Complement component C9 | Tier 1.5 | 0.796 | 9 | 78.75 | 1 | 0 | 1 | 10 | 41636061, 40411682, 36428893, 36290981, 35247355, 28794177, 27836219, 22678933, 19261617, 15687383 | 1 | Immunodeficiency due to a late component of complements deficiency | 0.761965409699055 | |||
| Q13085 | ACACA | Acetyl-CoA carboxylase 1 | Tier 1.5 | 0.79 | 10 | 82.81 | 1 | 0 | 1 | 1 | 41854184 | 1 | |||||
| Q92633 | LPAR1 | Lysophosphatidic acid receptor 1 | Tier 1.5 | 0.785 | 16 | 83.62 | 1 | 0 | 1 | 1 | 32065590 | 1 | Epiretinal membrane | 0.4757255248053499 | |||
| P39060 | COL18A1 | Collagen alpha-1(XVIII) chain | Tier 1.5 | 0.769 | 9 | 50.62 | 1 | 0 | 1 | 2 | 36707842, 23679916 | 1 | Knobloch syndrome 1 | 0.7867122552672962 | |||
| O60568 | PLOD3 | Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 | Tier 1.5 | 0.762 | 18 | 91.38 | 1 | 0 | 0 | 0 | 1 | bone fragility with contractures, arterial rupture, and deafness | 0.7159150369336311 | ||||
| P41440 | SLC19A1 | Reduced folate transporter | Tier 1.5 | 0.755 | 19 | 72.06 | 1 | 0 | 0 | 0 | 1 | Knobloch syndrome | 0.5526223217595396 | ||||
| P43007 | SLC1A4 | Neutral amino acid transporter A | Tier 1.5 | 0.75 | 1 | 80.56 | 1 | 0 | 1 | 6 | 36219068, 31989939, 27571928, 26811678, 19046328, 16139842 | 1 | spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome | 0.8025684205131692 | |||
| P26022 | PTX3 | Pentraxin-related protein PTX3 | Tier 1.5 | 0.75 | 9 | 76.75 | 1 | 0 | 0 | 0 | 1 | polycystic ovary syndrome | 0.12287624125782433 | ||||
| P08648 | ITGA5 | Integrin alpha-5 | Tier 1.5 | 0.748 | 14 | 85.25 | 1 | 0 | 1 | 2 | 32174798, 38258032 | 1 | skin disease | 0.28465651599598124 | |||
| Q9Y653 | ADGRG1 | Adhesion G-protein coupled receptor G1 | Tier 1.5 | 0.743 | 1 | 77.88 | 1 | 0 | 0 | 0 | 1 | bilateral frontoparietal polymicrogyria | 0.8322298896713178 | ||||
| O60884 | DNAJA2 | DnaJ homolog subfamily A member 2 | Tier 1.5 | 0.73 | 1 | 83.38 | 1 | 0 | 1 | 2 | 41935727, 33879515 | 1 | dengue disease | 0.37068859424875583 | |||
| P07942 | LAMB1 | Laminin subunit beta-1 | Tier 1.5 | 0.72 | 3 | 76.69 | 1 | 0 | 0 | 0 | 1 | cobblestone lissencephaly without muscular or ocular involvement | 0.8016665947624902 | ||||
| Q99988 | GDF15 | Growth/differentiation factor 15 | Tier 1.5 | 0.718 | 4 | 75.69 | 1 | 0 | 1 | 29 | 41924874, 41862097, 38879214, 38477735, 37982669, 36927042, 36638554, 36508319, 36333824, 35762561, 33334063, 32527800, 31988066, 29992704, 39884764, 38497478, 38296402, 37162508, 32739349, 30335547 | 1 | hyperemesis gravidarum | 0.5821658682742563 | |||
| Q9NR82 | KCNQ5 | Potassium voltage-gated channel subfamily KQT member 5 | Tier 1.5 | 0.711 | 5 | 56.41 | 1 | 0 | 0 | 0 | 1 | intellectual disability, autosomal dominant 46 | 0.7086662845211597 | ||||
| P14770 | GP9 | Platelet glycoprotein IX | Tier 1.5 | 0.702 | 2 | 84.69 | 1 | 0 | 0 | 0 | 1 | Bernard-Soulier syndrome | 0.8233582238860002 | ||||
| P07225 | PROS1 | Vitamin K-dependent protein S | Tier 1.5 | 0.7 | 3 | 82.94 | 1 | 0 | 1 | 2 | 36859809, 33674695 | 1 | thrombophilia due to protein S deficiency, autosomal dominant | 0.8240418292042652 | |||
| P21359 | NF1 | Neurofibromin | Tier 1.5 | 0.695 | 26 | 87.19 | 1 | 0 | 1 | 2 | 32980430, 22617876 | 1 | neurofibromatosis type 1 | 0.8844735398780649 | |||
| P01825 | IGHV4-59 | Immunoglobulin heavy variable 4-59 | Tier 1.5 | 0.69 | 3 | 91.56 | 1 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | ||||
| Q6NT16 | SLC18B1 | MFS-type transporter SLC18B1 | Tier 1.5 | 0.688 | 4 | 84.62 | 1 | 0 | 0 | 0 | 1 | Parkinson disease | 0.276931649354752 | ||||
| Q99250 | SCN2A | Sodium channel protein type 2 subunit alpha | Tier 1.5 | 0.685 | 5 | 68.81 | 1 | 0 | 0 | 0 | 1 | developmental and epileptic encephalopathy, 11 | 0.8388748085806758 | ||||
| Q15582 | TGFBI | Transforming growth factor-beta-induced protein ig-h3 | Tier 1.5 | 0.682 | 10 | 90.25 | 1 | 0 | 0 | 0 | 1 | lattice corneal dystrophy type I | 0.8242841141270143 | ||||
| Q8TD43 | TRPM4 | Transient receptor potential cation channel subfamily M member 4 | Tier 1.5 | 0.68 | 25 | 77.44 | 1 | 0 | 0 | 0 | 1 | Familial progressive cardiac conduction defect | 0.7868180621357534 | ||||
| O75935 | DCTN3 | Dynactin subunit 3 | Tier 1.5 | 0.68 | 1 | 88.38 | 1 | 0 | 0 | 0 | 1 | viral disease | 0.03700998752471888 | ||||
| P05023 | ATP1A1 | Sodium/potassium-transporting ATPase subunit alpha-1 | Tier 1.5 | 0.679 | 10 | 88.69 | 1 | 0 | 0 | 0 | 1 | Charcot-Marie-tooth disease, axonal, type 2DD | 0.7868851290226483 | ||||
| Q92536 | SLC7A6 | Y+L amino acid transporter 2 | Tier 1.5 | 0.678 | 2 | 83.19 | 1 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.48544421359843914 | ||||
| P18564 | ITGB6 | Integrin beta-6 | Tier 1.5 | 0.675 | 14 | 82.88 | 1 | 0 | 0 | 0 | 1 | Hypoplastic amelogenesis imperfecta | 0.6045342804405103 | ||||
| P36021 | SLC16A2 | Monocarboxylate transporter 8 | Tier 1.5 | 0.675 | 7 | 79.56 | 1 | 0 | 0 | 0 | 1 | Allan-Herndon-Dudley syndrome | 0.8533069932022032 | ||||
| P32241 | VIPR1 | Vasoactive intestinal polypeptide receptor 1 | Tier 1.5 | 0.667 | 17 | 76.0 | 1 | 0 | 0 | 0 | 1 | diverticular disease | 0.2747596866638145 | ||||
| O95563 | MPC2 | Mitochondrial pyruvate carrier 2 | Tier 1.5 | 0.665 | 17 | 89.44 | 1 | 0 | 0 | 0 | 1 | mitochondrial pyruvate carrier deficiency | 0.18534429712437792 | ||||
| O15554 | KCNN4 | Intermediate conductance calcium-activated potassium channel protein 4 | Tier 1.5 | 0.661 | 17 | 84.19 | 1 | 0 | 0 | 0 | 1 | dehydrated hereditary stomatocytosis | 0.7145864899974032 | ||||
| P98155 | VLDLR | Very low-density lipoprotein receptor | Tier 1.5 | 0.66 | 27 | 75.69 | 1 | 0 | 1 | 1 | 19188685 | 1 | Dysequilibrium syndrome | 0.790164037509625 | |||
| P13637 | ATP1A3 | Sodium/potassium-transporting ATPase subunit alpha-3 | Tier 1.5 | 0.654 | 5 | 88.81 | 1 | 0 | 0 | 0 | 1 | alternating hemiplegia of childhood 2 | 0.842328126568451 | ||||
| Q14524 | SCN5A | Sodium channel protein type 5 subunit alpha | Tier 1.5 | 0.654 | 16 | 67.25 | 1 | 0 | 0 | 0 | 1 | long QT syndrome 3 | 0.8448298602976083 | ||||
| P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | Tier 1.5 | 0.652 | 14 | 72.69 | 1 | 0 | 1 | 4 | 33334063, 32127469, 28010895, 30594071 | 1 | gastrointestinal stromal tumor | 0.8167494524079806 | |||
| O60449 | LY75 | Lymphocyte antigen 75 | Tier 1.5 | 0.65 | 4 | 75.62 | 1 | 0 | 0 | 0 | 1 | Abruptio Placentae | 0.31953367678705413 | ||||
| O00468 | AGRN | Agrin | Tier 1.5 | 0.649 | 1 | 68.81 | 1 | 0 | 0 | 0 | 1 | congenital myasthenic syndrome 8 | 0.7912009864338403 | ||||
| Q15027 | ACAP1 | Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 | Tier 1.5 | 0.649 | 7 | 84.38 | 1 | 0 | 0 | 0 | 1 | hypothyroidism | 0.4891091360736571 | ||||
| O00478 | BTN3A3 | Butyrophilin subfamily 3 member A3 | Tier 1.5 | 0.648 | 9 | 82.81 | 1 | 0 | 0 | 0 | 1 | neoplasm | 0.07870866954589865 | ||||
| P07237 | P4HB | Protein disulfide-isomerase | Tier 1.5 | 0.644 | 14 | 88.5 | 1 | 0 | 1 | 2 | 31625090, 28952381 | 1 | Cole-Carpenter syndrome | 0.7447295842045853 | |||
| Q8TEM1 | NUP210 | Nuclear pore membrane glycoprotein 210 | Tier 1.5 | 0.644 | 2 | 79.56 | 1 | 0 | 0 | 0 | 1 | HIV infection | 0.5409211817593593 | ||||
| Q9Y4R8 | TELO2 | Telomere length regulation protein TEL2 homolog | Tier 1.5 | 0.64 | 3 | 83.88 | 1 | 0 | 0 | 0 | 1 | TELO2-related intellectual disability-neurodevelopmental disorder | 0.7971337980726797 | ||||
| O60443 | GSDME | Gasdermin-E | Tier 1.5 | 0.638 | 2 | 77.44 | 1 | 0 | 0 | 0 | 1 | autosomal dominant nonsyndromic hearing loss | 0.6288670542083885 | ||||
| P00846 | MT-ATP6 | ATP synthase F(0) complex subunit a | Tier 1.5 | 0.636 | 10 | 88.94 | 1 | 0 | 0 | 0 | 1 | NARP syndrome | 0.760749518172638 | ||||
| P21731 | TBXA2R | Thromboxane A2 receptor | Tier 1.5 | 0.634 | 6 | 86.25 | 1 | 0 | 0 | 0 | 1 | bleeding diathesis due to thromboxane synthesis deficiency | 0.639967145559869 | ||||
| O75976 | CPD | Carboxypeptidase D | Tier 1.5 | 0.625 | 3 | 82.5 | 1 | 0 | 1 | 1 | 36457699 | 1 | neurodegenerative disease | 0.34777406871587735 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS SELECT f.id, n.gene_symbol, n.protein_name, tg.tier, f.priority_score, f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM, f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive, f.drug_count_approved, f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids, f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score FROM v_target_full f LEFT JOIN target_names n ON n.target_id=f.id LEFT JOIN targets tg ON tg.id=f.id LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id;